Over half of HF patients today have a preserved ejection fraction (HFpEF) and so we now turn our attention in HL61912 to HFpEF because of its growing prevalence, high mortality, exorbitant costs, poorly understood pathophysiology, and the lack of a proven treatment. Because there are no accepted HFpEF animal models, mechanistic human studies are needed to identify and understand the factors that contribute to this systemic, global process that results in profound exercise intolerance (EI). We present new data here that HFpEF patients manifest significant abnormalities in both cardiac and skeletal muscle high-energy phosphate (HEP) metabolism and propose to determine their relationship to EI and clinical HF symptoms as well as disease progression for the first time in HFpEF patients. This proposal will exploit three new state-of-the-art noninvasive tools developed by the investigators and not available elsewhere in the US to quantify a) myocardial energy metabolism and energetic reserve at rest, b) skeletal muscle energy metabolism with a newly developed skeletal muscle energetic fatigability test, and c) nitric oxide-mediated coronary endothelial function (CEF). The main premise of this work is that energetic abnormalities in cardiac and/or skeletal muscle, potentially worsened by abnormal endothelial function, contribute independently to the development of exercise intolerance and predict subsequent heart failure hospitalizations and cardiovascular deaths. Thus the new in vivo metabolic findings will be related to established, conventional clinical HF indices, diastolic function, biomarkers, and objective measures of exercise intolerance in both cross-sectional and longitudinal fashion (6 months). Moreover, we will determine whether abnormal cardiac and/or skeletal muscle energetics independently predict exercise intolerance and heart failure clinical outcomes over 2 years. A broad investigative approach is important because HFpEF pathophysiology is thought to involve several interrelated systems (including diastolic dysfunction, vascular/endothelial dysfunction, peripheral mechanisms, and impaired energetics). These unique physiologic studies of myocardial, skeletal and coronary vascular changes promise to guide new diagnostic/phenotyping approaches in HFpEF, uncover critical relationships and mechanisms in HFpEF, termed by experts as the number one unmet need in cardiovascular medicine today.

Public Health Relevance

Heart failure is a deadly condition that limits a person's ability to perform many physical activities of daily living. These studies are designed to help us understand whether changes in the ways that our hearts and skeletal muscles convert and use (metabolize) food fuels are altered in heart failure and whether those metabolic changes contribute to disability and heart failure progression in patients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL061912-15A1
Application #
9309536
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Evans, Frank
Project Start
1999-07-19
Project End
2021-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
15
Fiscal Year
2017
Total Cost
$627,161
Indirect Cost
$129,414
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Bonanno, Gabriele; Hays, Allison G; Weiss, Robert G et al. (2018) Self-gated golden angle spiral cine MRI for coronary endothelial function assessment. Magn Reson Med 80:560-570
Hays, Allison G; Iantorno, Micaela; Schär, Michael et al. (2017) Local coronary wall eccentricity and endothelial function are closely related in patients with atherosclerotic coronary artery disease. J Cardiovasc Magn Reson 19:51
Weiss, Kilian; Schär, Michael; Panjrath, Gurusher S et al. (2017) Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure. Circ Heart Fail 10:
Iantorno, Micaela; Hays, Allison G; Schär, Michael et al. (2016) Simultaneous Noninvasive Assessment of Systemic and Coronary Endothelial Function. Circ Cardiovasc Imaging 9:e003954
Weiss, Kilian; Bottomley, Paul A; Weiss, Robert G (2015) On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo ³¹P MRS. NMR Biomed 28:694-705
Zhang, Yi; Zhou, Jinyuan; Bottomley, Paul A (2015) Minimizing lipid signal bleed in brain (1) H chemical shift imaging by post-acquisition grid shifting. Magn Reson Med 74:320-9
Schär, Michael; Gabr, Refaat E; El-Sharkawy, AbdEl-Monem M et al. (2015) Two repetition time saturation transfer (TwiST) with spill-over correction to measure creatine kinase reaction rates in human hearts. J Cardiovasc Magn Reson 17:70
Soleimanifard, Sahar; Stuber, Matthias; Hays, Allison G et al. (2014) Robust volume-targeted balanced steady-state free-precession coronary magnetic resonance angiography in a breathhold at 3.0 Tesla: a reproducibility study. J Cardiovasc Magn Reson 16:27
Bottomley, Paul A; Panjrath, Gurusher S; Lai, Shenghan et al. (2013) Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med 5:215re3
Hays, Allison G; Stuber, Matthias; Hirsch, Glenn A et al. (2013) Non-invasive detection of coronary endothelial response to sequential handgrip exercise in coronary artery disease patients and healthy adults. PLoS One 8:e58047

Showing the most recent 10 out of 66 publications